No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
No Data
Dynacure Receives Fast Track Designation for DYN101, an Investigational Antisense Oligonucleotide for the Treatment of Myotubular and Centronuclear Myopathies
Dynacure to Present at 40th Annual J.P. Morgan Healthcare Conference
BRIEF-Dynacure Announces Strategic Collaboration And Option Agreement With Nippon Shinyaku
NASDAQ TRADE HALT DYCU.O REASON NOT AVAILABLE AT 04:00 AM
No Data
thamwh19 : Good
Kenji Leow KC : wow![clap 👏](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f44f.png)
![open_mouth 😮](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f62e.png)
![clap 👏](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f44f.png)
steady Pom pipi :![undefined undefined](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)